Authors:
BARDITCHCROVO P
TOOLE J
HENDRIX CW
CUNDY KC
EBELING D
JAFFE HS
LIETMAN PS
Citation: P. Barditchcrovo et al., ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ACTIVITY, SAFETY, AND PHARMACOKINETICS OF ADEFOVIR DIPIVOXIL PIVALOYLOXYMETHYL)-PHOSPHONYLMETHOXYETHYL]ADENINE) IN HIV-INFECTED PATIENTS, The Journal of infectious diseases, 176(2), 1997, pp. 406-413
Authors:
SCHMIDT H
EBELING D
BAUER H
BOHRER H
GEBHARD MM
MARTIN E
Citation: H. Schmidt et al., INFLUENCE OF THE PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONIST BN52021 ON ENDOTOXIN-INDUCED LEUKOCYTE ADHERENCE IN RAT MESENTERIC VENULES, The Journal of surgical research, 60(1), 1996, pp. 29-35
Authors:
SCHMIDT H
EBELING D
BAUER H
BACH A
BOHRER H
GEBHARD MM
MARTIN E
Citation: H. Schmidt et al., KETAMINE ATTENUATES ENDOTOXIN-INDUCED LEUKOCYTE ADHERENCE IN RAT MESENTERIC VENULES, Critical care medicine, 23(12), 1995, pp. 2008-2014
Authors:
CUNDY KC
BARDITCHCROVO P
WALKER RE
COLLIER AC
EBELING D
TOOLE J
JAFFE HS
Citation: Kc. Cundy et al., CLINICAL PHARMACOKINETICS OF ADEFOVIR IN HUMAN-IMMUNODEFICIENCY-VIRUSTYPE 1-INFECTED PATIENTS, Antimicrobial agents and chemotherapy, 39(11), 1995, pp. 2401-2405